Pier 88 Investment Partners »

Halozyme Therapeutics shares owned by Pier 88 Investment Partners

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Pier 88 Investment Partners from 13F filings

Historical chart of Pier 88 Investment Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Pier 88 Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Pier 88 Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $82k 71k 1.15

More positions owned by Pier 88 Investment Partners

Bank America Corp 7.25 Percentage Cnv Pfd L Convertible Preferred (BAC.PL)
Wells Fargo Co New Perp Pfd Cnv A Convertible Preferred (WFC.PL)
Etsy Note 0.250% 6/1 (Principal)
Global Pmts Note 1.500% 3/0 (Principal)
Ford Mtr Note 3/1 (Principal)
Alliant Energy Corp Note 3.875% 3/1 (Principal)
Ventas Rlty Ltd Partnership Note 3.750% 6/0 (Principal)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)
Okta Note 0.375% 6/1 (Principal)
Shift4 Pmts Note 0.500% 8/0 (Principal)
Uber Technologies Note 0.875%12/0 (Principal)
Meritage Homes Corp Note 1.750% 5/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv Convertible Preferred (HPE.PC)
Kkr & Co Inc 6.25 Con Ser D Convertible Preferred (KKR.PD)
American Wtr Cap Corp Note 3.625% 6/1 (Principal)

View all positions for Pier 88 Investment Partners

Top funds holding Halozyme Therapeutics

Steelhead Partners
Opti Capital Management
Linden Advisors
Millennium Management
MacKay Shields
DeepCurrents Investment Group
Tenor Capital Management
BlackRock
Lazard Asset Management
M&G
Calamos Advisors
Wellesley Investment Advisors
UBS O'Connor
Jpmorgan Chase & Co
State Street Corporation

View all funds holding Halozyme Therapeutics